The abstract is read at the publisher; the summary is JClub's.
OptoDRD1, a bistable JSR1-S199F-based optoGPCR, enables reversible violet/green light control of Gs signalling with sustained cAMP output and rapid deactivation.
- Why it matters: Existing optoGPCRs are often monostable, limiting experiments by photobleaching and irreversibility, and leaving few reversible tools for Gs pathways.
- What they did: The authors engineered JSR1-S199F using AlphaFold-guided receptor–miniGs design and screened intracellular domain chimeras, identifying ICL2, ICL3, helix 8, and the DRD1 C-terminus; optoDRD1 uses {lambda}max 397 nm and 531 nm.
- The result: A single violet pulse sustains Gs signalling for several hours, while green light deactivates at chosen time points over multiple cycles, matching wild-type DRD1 cAMP kinetics and enabling optogenetic control of insulin secretion in human beta-cells and neuronal signalling.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.